S. Roy

709 total citations
22 papers, 503 citations indexed

About

S. Roy is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Surgery. According to data from OpenAlex, S. Roy has authored 22 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 5 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in S. Roy's work include Reproductive Health and Contraception (4 papers), Urinary Tract Infections Management (4 papers) and Reproductive tract infections research (3 papers). S. Roy is often cited by papers focused on Reproductive Health and Contraception (4 papers), Urinary Tract Infections Management (4 papers) and Reproductive tract infections research (3 papers). S. Roy collaborates with scholars based in United States, United Kingdom and Lebanon. S. Roy's co-authors include Alexander Duke, Malcolm C. Pike, Brian E. Henderson, Mark Krailo, James C. Caillouette, J. Wilkins, C. Azen, Richard M. Watanabe, Jeffrey A. Perlman and Richard N. Bergman and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and American Journal of Public Health.

In The Last Decade

S. Roy

21 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Roy United States 9 165 144 132 120 100 22 503
Kari S. Lankinen Finland 11 62 0.4× 34 0.2× 147 1.1× 149 1.2× 28 0.3× 15 619
Hany Salem Saudi Arabia 11 49 0.3× 71 0.5× 27 0.2× 35 0.3× 66 0.7× 41 318
H. Mete Tanir Türkiye 15 226 1.4× 22 0.2× 40 0.3× 32 0.3× 199 2.0× 50 634
Luciana Costa Faria Brazil 12 64 0.4× 34 0.2× 78 0.6× 25 0.2× 65 0.7× 42 570
Linda Ahenkorah Fondjo Ghana 16 128 0.8× 66 0.5× 75 0.6× 34 0.3× 7 0.1× 48 646
Magdi M. Salih Sudan 13 156 0.9× 45 0.3× 56 0.4× 17 0.1× 13 0.1× 47 585
J Janssens Belgium 11 52 0.3× 65 0.5× 43 0.3× 62 0.5× 5 0.1× 26 352
Scott Quinlan United States 10 16 0.1× 190 1.3× 93 0.7× 102 0.8× 9 0.1× 23 424
Raffaella Depalo Italy 17 444 2.7× 24 0.2× 34 0.3× 30 0.3× 633 6.3× 43 874
Afsaneh Sharifian Iran 9 143 0.9× 18 0.1× 211 1.6× 32 0.3× 12 0.1× 29 514

Countries citing papers authored by S. Roy

Since Specialization
Citations

This map shows the geographic impact of S. Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Roy more than expected).

Fields of papers citing papers by S. Roy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Roy. The network helps show where S. Roy may publish in the future.

Co-authorship network of co-authors of S. Roy

This figure shows the co-authorship network connecting the top 25 collaborators of S. Roy. A scholar is included among the top collaborators of S. Roy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Roy. S. Roy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Awuah, Wireko Andrew, et al.. (2025). The transformative power of telemedicine in delivering effective neurosurgical care in low and middle-income countries: A review. Brain and Spine. 5. 104269–104269. 3 indexed citations
3.
Uwishema, Olivier, et al.. (2025). A Wake‐Up Call: Can Africa Sustain HIV/AIDS Programs Without Foreign Aid?. Health Science Reports. 8(9). e71248–e71248.
4.
Roy, S., et al.. (2024). The Critical Need for Disaster Medicine in Modern Medical Education. Disaster Medicine and Public Health Preparedness. 18. e80–e80. 1 indexed citations
5.
Roy, S., et al.. (2024). Evolving perspectives in reverse cardio-oncology: A review of current status, pathophysiological insights, and future directives. Current Problems in Cardiology. 49(3). 102389–102389. 5 indexed citations
6.
Aung, K. J. M., et al.. (2012). Extension of the intensive phase reduces relapse but not failure in a regimen with rifampicin throughout. The International Journal of Tuberculosis and Lung Disease. 16(4). 455–461. 11 indexed citations
7.
Hodis, Howard N., et al.. (2008). Medroxyprogesterone Acetate and Progesterone, Used Short Term, Do not Adversely Affect Forearm Reactive Hyperemia in Postmenopausal Women on Estradiol Therapy. International Journal of Endocrinology and Metabolism. 6(2). 63–69. 1 indexed citations
8.
McGonigle, Kathryn F., David Smith, R.J. Morgan, et al.. (2006). Uterine effects of tamoxifen: a prospective study. International Journal of Gynecological Cancer. 16(2). 814–820. 10 indexed citations
9.
Roy, S., et al.. (2005). The role of an over-the-counter vaginal pH self-test device package insert: Can subjects learn what the device is for and how to use it?. American Journal of Obstetrics and Gynecology. 192(6). 1963–1967. 6 indexed citations
10.
Roy, S., et al.. (2004). Vaginal pH is similar to follicle-stimulating hormone for menopause diagnosis. American Journal of Obstetrics and Gynecology. 190(5). 1272–1277. 67 indexed citations
11.
Saadat, Peyman, et al.. (2002). A randomized prospective study comparing the effects of micronized progesterone and medroxyprogesterone acetate on mood and libido. Fertility and Sterility. 77. S21–S21. 1 indexed citations
12.
Boostanfar, R., et al.. (2001). Serum endocrine markers and psychosexual mood in postmenopausal women: is there a difference between transdermal and oral HRT?. Fertility and Sterility. 76(3). S53–S53. 1 indexed citations
13.
Slater, Cristin C., et al.. (2000). Dihydrotestosterone (dht) accumulation as a consequence of long-term dhea supplementation in postmenopausal women. Fertility and Sterility. 73(4). S7–S8. 1 indexed citations
14.
Biswas, Arnab & S. Roy. (1996). A comparative study of the efficacy and safety of synthetic prostaglandin E2 derivative and 15-methyl prostaglandin F2 alpha in the termination of midtrimester pregnancy.. PubMed. 94(8). 292–3. 1 indexed citations
15.
Sweet, Richard L., S. Roy, S Faro, et al.. (1994). Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.. PubMed. 83(2). 280–6. 32 indexed citations
16.
Watanabe, Richard M., C. Azen, S. Roy, Jeffrey A. Perlman, & Richard N. Bergman. (1994). Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factors.. The Journal of Clinical Endocrinology & Metabolism. 79(5). 1277–1283. 47 indexed citations
17.
Roy, S., J. Wilkins, Charles M. March, et al.. (1990). Cefmetazole and cefonicid. Comparative efficacy and safety in preventing postoperative infections after vaginal and abdominal hysterectomy.. PubMed. 35(11 Suppl). 1082–90. 2 indexed citations
18.
Ross, Rachael K., Annlia Paganini‐Hill, S. Roy, Ann Chao, & B E Henderson. (1988). Past and present preferred prescribing practices of hormone replacement therapy among Los Angeles gynecologists: possible implications for public health.. American Journal of Public Health. 78(5). 516–519. 31 indexed citations
19.
Roy, S. & J. Wilkins. (1985). Cefotaxime in the treatment of female pelvic soft tissue infections. Infection. 13(S1). S56–S61. 4 indexed citations
20.
Roy, S. & J. Wilkins. (1984). Single-dose cefotaxime versus 3 to 5 dose cefoxitin for prophylaxis of vaginal or abdominal hysterectomy. Journal of Antimicrobial Chemotherapy. 14(suppl B). 217–221. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026